Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 3
2010 2
2013 2
2014 1
2015 3
2016 2
2018 1
2019 1
2020 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
Valent P, Akin C, Arock M, Gleixner KV, Greinix H, Hermine O, Horny HP, Ivanov D, Orfao A, Rabitsch W, Reiter A, Schulenburg A, Sotlar K, Sperr WR, Ustun C. Valent P, et al. Among authors: schulenburg a. Int J Mol Sci. 2023 Oct 12;24(20):15125. doi: 10.3390/ijms242015125. Int J Mol Sci. 2023. PMID: 37894806 Free PMC article. Review.
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives.
Valent P, Sadovnik I, Peter B, Ivanov D, Schulenburg A, Hadzijusufovic E, Willmann M, Rülicke T, Herrmann H, Rabitsch W, Karlic H, Gleixner KV, Sperr WR, Hoermann G, Dahlhoff M, Pfeilstöcker M, Keil F, Lion T, Grunt TW. Valent P, et al. Among authors: schulenburg a. Expert Rev Hematol. 2023 Jul-Dec;16(9):659-670. doi: 10.1080/17474086.2023.2232545. Epub 2023 Jul 27. Expert Rev Hematol. 2023. PMID: 37493441 Review.
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria.
Knaus HA, Rottner T, Baumann CK, Cserna J, Mitterbauer M, Schulenburg A, Rabitsch W, Wohlfarth P. Knaus HA, et al. Among authors: schulenburg a. Transplant Cell Ther. 2022 May;28(5):260.e1-260.e9. doi: 10.1016/j.jtct.2022.02.016. Epub 2022 Feb 22. Transplant Cell Ther. 2022. PMID: 35217212 Free article.
Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
Herrmann H, Sadovnik I, Eisenwort G, Rülicke T, Blatt K, Herndlhofer S, Willmann M, Stefanzl G, Baumgartner S, Greiner G, Schulenburg A, Mueller N, Rabitsch W, Bilban M, Hoermann G, Streubel B, Vallera DA, Sperr WR, Valent P. Herrmann H, et al. Among authors: schulenburg a. Blood Adv. 2020 Oct 27;4(20):5118-5132. doi: 10.1182/bloodadvances.2020001742. Blood Adv. 2020. PMID: 33085758 Free PMC article.
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives.
Valent P, Hadzijusufovic E, Grunt T, Karlic H, Peter B, Herrmann H, Eisenwort G, Hoermann G, Schulenburg A, Willmann M, Hubmann R, Shehata M, Selzer E, Gleixner KV, Rülicke T, Sperr WR, Marian B, Pfeilstöcker M, Pehamberger H, Keil F, Jäger U, Zielinski C. Valent P, et al. Among authors: schulenburg a. Wien Klin Wochenschr. 2018 Sep;130(17-18):517-529. doi: 10.1007/s00508-018-1355-7. Epub 2018 Jul 13. Wien Klin Wochenschr. 2018. PMID: 30006759 Free PMC article. Review.
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
Vogl U, Leitner G, Dal-Bianco A, Bojic M, Mitterbauer M, Rabitsch W, Kalhs P, Schulenburg A. Vogl U, et al. Among authors: schulenburg a. Wien Klin Wochenschr. 2016 May;128(9-10):384-6. doi: 10.1007/s00508-016-0972-2. Epub 2016 Feb 26. Wien Klin Wochenschr. 2016. PMID: 26919852 Free PMC article.
Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation.
Bojic M, Worel N, Sperr WR, Schellongowski P, Wohlfarth P, Schwarzinger I, Mitterbauer-Hohendanner G, Fischer G, Dieckmann KU, Lamm W, Leiner M, Schulenburg A, Mitterbauer M, Greinix HT, Kalhs P, Rabitsch W. Bojic M, et al. Among authors: schulenburg a. Oncology. 2016;90(3):160-6. doi: 10.1159/000443767. Epub 2016 Feb 13. Oncology. 2016. PMID: 26871562
23 results